Literature DB >> 22249780

Cardiovascular disease: salt and cardiovascular risk.

Feng J He1, Graham A MacGregor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22249780     DOI： 10.1038/nrneph.2011.220

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  7 in total

Review 1.  Reducing population salt intake worldwide: from evidence to implementation.

Authors:  Feng J He; Graham A MacGregor
Journal:  Prog Cardiovasc Dis       Date:  2010 Mar-Apr       Impact factor: 8.194

2.  Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials.

Authors:  Feng J He; Graham A MacGregor
Journal:  Lancet       Date:  2011-07-30       Impact factor: 79.321

3.  Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET).

Authors:  Giuseppe Mancia; Helmut Schumacher; Josep Redon; Paolo Verdecchia; Roland Schmieder; Garry Jennings; Khalid Yusoff; Lars Ryden; G Lisheng Liu; Koon Teo; Peter Sleight; Salim Yusuf
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

4.  Urinary sodium and potassium excretion and risk of cardiovascular events.

Authors:  Martin J O'Donnell; Salim Yusuf; Andrew Mente; Peggy Gao; Johannes F Mann; Koon Teo; Matthew McQueen; Peter Sleight; Arya M Sharma; Antonio Dans; Jeffrey Probstfield; Roland E Schmieder
Journal:  JAMA       Date:  2011-11-23       Impact factor: 56.272

5.  Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?

Authors:  Salvatore Paterna; Parrinello Gaspare; Sergio Fasullo; Filippo M Sarullo; Pietro Di Pasquale
Journal:  Clin Sci (Lond)       Date:  2008-02       Impact factor: 6.124

6.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP).

Authors:  Nancy R Cook; Jeffrey A Cutler; Eva Obarzanek; Julie E Buring; Kathryn M Rexrode; Shiriki K Kumanyika; Lawrence J Appel; Paul K Whelton
Journal:  BMJ       Date:  2007-04-20

Review 7.  Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies.

Authors:  Pasquale Strazzullo; Lanfranco D'Elia; Ngianga-Bakwin Kandala; Francesco P Cappuccio
Journal:  BMJ       Date:  2009-11-24
  7 in total
  4 in total

Review 1.  Salt and gene expression: evidence for [Na+]i/[K+]i-mediated signaling pathways.

Authors:  Sergei N Orlov; Pavel Hamet
Journal:  Pflugers Arch       Date:  2014-12-06       Impact factor: 3.657

Review 2.  Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease.

Authors:  Xin Zhou; Jian-Min Niu; Wen-Jie Ji; Zhuoli Zhang; Peizhong P Wang; Xue-Feng B Ling; Yu-Ming Li
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

3.  Renal outcomes and dietary potassium: the overshadowed electrolyte?

Authors:  Kristen L Jablonski; Jessica B Kendrick
Journal:  Kidney Int       Date:  2014-12       Impact factor: 10.612

4.  Arcuate NPY is involved in salt-induced hypertension via modulation of paraventricular vasopressin and brain-derived neurotrophic factor.

Authors:  Chen-Liang Zhang; Yi-Zhang Lin; Qi Wu; Chenxu Yan; Matthew Wai-Kin Wong; Fan Zeng; Ping Zhu; Kelsey Bowes; Kailun Lee; Xuan Zhang; Zhi-Yuan Song; Shu Lin; Yan-Chuan Shi
Journal:  J Cell Physiol       Date:  2022-03-21       Impact factor: 6.513
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.